戻る Agenda
Round Table Discussion: Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned?
Session Chair(s)
Mary Murray, MBA, MS
Family Caregiver
Independent Consultant, United States
Join DIA Patient Engagement Community for a round table discussion tied to session #310 SL Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned? scheduled for Wednesday, June 30 3-4 PM EDT. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.
Speaker(s)
Theresa Mullin, PhD
FDA, United States
Associate Center Director - CDER
François Houyez
European Organisation for Rare Diseases (EURORDIS), France
Treatment Information and Access Director, Health Policy Advisor
Lembit Rago, DrMed, MD, PhD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General
Juan Garcia-Burgos, MD, PhD
European Medicines Agency, Netherlands
Head of Public and Stakeholders Engagement Department
Talia Lacroix, MPA
Health Canada, Canada
Senior Policy Analyst, Health Product and Food Branch